Coronavirus (612) The Lancet: What policymakers need to know about immunity (2)

16 May, 2020

Neil, thank you forsharing. On this form we have in recent times discussed evidence based policy alot. The Lancet paper made us look at some of the points raised in the past andhow the concept is playing out in COVID-19 pandemic.

We refer to one ofthe definitions of Evidence Based policy Making, ‘Evidence to inform policy-makers can be sought in different ways, depending on several factors,including: the timeframe in which the researcher has to operate (how quickly apolicy-maker requires a response), the resources available and the type of evidence required (for example, global or local). The nature of the query orpolicy maker’s request dictates the type of evidence and how it is madeavailable. If no evidence is found, the alternative measures available mayrequire consideration- (WHO/Europe | Evidence-informed policy-making: www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making).

The circumstances of COVID-19 pandemic satisfies the various indicators in this definition: ‘timeframe’ in which the researcher has to produce results, for the policy makers and the public; ‘resources’available, in the case of COVID-19 the catastrophic economic impact on all nations already reduces resources further. The nature of the request in this COVID-19 era is further complicated by elections that will take place in major countries that ordinarily shape world opinion.

The recent call by World Leaders inthe release, ‘World leaders in call for a people’s vaccine against COVID-19’becomes very apt. ‘More than 140 world leaders, experts and elders made the unprecedented call for guarantees that COVID-19 vaccines, diagnostics, tests and treatments will be provided free of charge to everyone, everywhere.’ https://www.unaids.org/en/resources/presscentre/pressreleaseandstatement...

Joseph Ana

HIFA Profile: Joseph Ana is the Lead Consultant and Trainer at the Africa Centre for Clinical Governance Research and Patient Safety in Calabar, Nigeria. In 2015 he won the NMA Award of Excellence for establishing 12-Pillar Clinical Governance, Quality and Safety initiative in Nigeria. He has been the pioneer Chairman of the Nigerian Medical Association (NMA) National Committee on Clinical Governance and Research since 2012. He is also Chairman of the Quality & Performance subcommittee of the Technical Working Group for the implementation of the Nigeria Health Act. He is a pioneer Trustee-Director of the NMF (Nigerian Medical Forum) which took the BMJ to West Africa in 1995. He is particularly interested in strengthening health systems for quality and safety in LMICs. He has written Five books on the 12-Pillar Clinical Governance for LMICs, including a TOOLS for Implementation. He established the Department of Clinical Governance, Servicom & e-health in the Cross River State Ministry of Health, Nigeria in 2007. Website: www.hriwestafrica.com Joseph is a member of the HIFA Steering Group and the HIFA working group on Community Health Workers.

http://www.hifa.org/support/members/joseph-0

http://www.hifa.org/people/steering-group

Email: jneana AT yahoo.co.uk